NCT01462227View on ClinicalTrials.gov

Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Hypoglycemia
Interventions
DRUG

Naltrexone High Dose

Naltrexone 100mg for two administrations.

DRUG

Naltrexone Low Dose

Naltrexone 50mg for two administrations.

Trial Locations (1)

06520

Yale School of Medicine, New Haven

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Yale University

OTHER

NCT01462227 - Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia | Biotech Hunter | Biotech Hunter